Abstract
Background: Sidr honey has been reported to exhibit antimicrobial activity against numerous pathogenic bacteria making this honey a promising functional food for the treatment of wounds or stomach ulcers.
Objective: The purpose of this study was to investigate the effect of Sidr honey against P. aeruginosa and S. pyogenes. Methods: Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) for Sidr honey were determined by the broth dilution method. The growth curve of both bacteria with MIC, half-MIC, and quarter-MIC was monitored by optical density (at OD570). The timekill curve was used to determine the bacteriostatic and bactericidal activity of Sidr honey on both bacteria by plotting colony-forming unit (CFUs) versus time. The effect of Sidr honey on the ultrastructure of the P. aeruginosa and S. pyogenes was investigated using scanning electron microscopy (SEM). The effect of Sidr honey on the expression of virulence genes in both bacteria was determined using quantitative reverse transcription-polymerase chain reaction (RT-qPCR). Results: The results showed that Sidr honey possessed the lowest MIC value against P. aeruginosa and S. pyogenes with 12.5% (w/v) and 20% (w/v), respectively. In addition, the MBC value for Sidr honey was found to be 20% (w/v) and 25% (w/v) against P. aeruginosa and S. pyogenes respectively. Growth curves conducted with MIC Sidr honey resulted in no growth of P. aeruginosa and S. pyogenes. Growth curves with half-MIC Sidr honey resulted in a reduced growth rate and reduction in overall cell number in both bacteria over a period of 24 h, compared with cells grown without honey. In the time-kill curve, treatment of P. aeruginosa and S. pyogenes with Sidr honey for 8 hours resulted in decreases of 4-log reduction (P < 0.05) in total viable counts (TVCs). SEM analysis revealed marked changes in the bacterial cell morphology for both bacteria following treatment with Sidr honey. These changes included the appearance of irregular shapes, incomplete cell division, and swelling cells. The RT-qPCR results showed that the expression of algD, oprF, fleN, fleQ, fleR, fliA, and fliC in P. aeruginosa decreased 0.43-fold, 0.38-fold, 0.41-fold, 0.51-fold, 0.40-fold, 0.61-fold, and 0.39-fold respectively after exposure to Sidr honey. Meanwhile, the expression of sof, sfbl, and scpA in S. pyogenes decreased 0.18-fold, 0.21-fold, and 0.28-fold respectively, after treated with Sidr honey. Conclusion: Using varying methods to evaluate the planktonic integrity, this study demonstrated that Sidr honey has antibacterial activity against both bacteria and has potential as a therapeutic agent for microbial infection, particularly against these two organisms. To our knowledge, this study is the first to indicate that Sidr honey is effective at inducing cell lysis and identify target genes at the genetic level that might be involved in this process.Keywords: Sidr honey, antibacterial activity, scanning electron microscopy (SEM), gene expression.
Graphical Abstract
Anti-Infective Agents
Title:Potential Antibacterial Activity of Yemeni Sidr Honey Against Pseudomonas aeruginosa and Streptococcus pyogenes
Volume: 19 Issue: 4
Author(s): Mohammad A. Al-kafaween*, Abu Bakar Mohd Hilmi, Hamid A. Nagi Al-Jamal*, Rania M. Al-Groom, Nour A. Elsahoryi and Hiba Al-Sayyed
Affiliation:
- Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Terengganu,Malaysia
- Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Terengganu,Malaysia
Keywords: Sidr honey, antibacterial activity, scanning electron microscopy (SEM), gene expression.
Abstract: Background: Sidr honey has been reported to exhibit antimicrobial activity against numerous pathogenic bacteria making this honey a promising functional food for the treatment of wounds or stomach ulcers.
Objective: The purpose of this study was to investigate the effect of Sidr honey against P. aeruginosa and S. pyogenes. Methods: Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) for Sidr honey were determined by the broth dilution method. The growth curve of both bacteria with MIC, half-MIC, and quarter-MIC was monitored by optical density (at OD570). The timekill curve was used to determine the bacteriostatic and bactericidal activity of Sidr honey on both bacteria by plotting colony-forming unit (CFUs) versus time. The effect of Sidr honey on the ultrastructure of the P. aeruginosa and S. pyogenes was investigated using scanning electron microscopy (SEM). The effect of Sidr honey on the expression of virulence genes in both bacteria was determined using quantitative reverse transcription-polymerase chain reaction (RT-qPCR). Results: The results showed that Sidr honey possessed the lowest MIC value against P. aeruginosa and S. pyogenes with 12.5% (w/v) and 20% (w/v), respectively. In addition, the MBC value for Sidr honey was found to be 20% (w/v) and 25% (w/v) against P. aeruginosa and S. pyogenes respectively. Growth curves conducted with MIC Sidr honey resulted in no growth of P. aeruginosa and S. pyogenes. Growth curves with half-MIC Sidr honey resulted in a reduced growth rate and reduction in overall cell number in both bacteria over a period of 24 h, compared with cells grown without honey. In the time-kill curve, treatment of P. aeruginosa and S. pyogenes with Sidr honey for 8 hours resulted in decreases of 4-log reduction (P < 0.05) in total viable counts (TVCs). SEM analysis revealed marked changes in the bacterial cell morphology for both bacteria following treatment with Sidr honey. These changes included the appearance of irregular shapes, incomplete cell division, and swelling cells. The RT-qPCR results showed that the expression of algD, oprF, fleN, fleQ, fleR, fliA, and fliC in P. aeruginosa decreased 0.43-fold, 0.38-fold, 0.41-fold, 0.51-fold, 0.40-fold, 0.61-fold, and 0.39-fold respectively after exposure to Sidr honey. Meanwhile, the expression of sof, sfbl, and scpA in S. pyogenes decreased 0.18-fold, 0.21-fold, and 0.28-fold respectively, after treated with Sidr honey. Conclusion: Using varying methods to evaluate the planktonic integrity, this study demonstrated that Sidr honey has antibacterial activity against both bacteria and has potential as a therapeutic agent for microbial infection, particularly against these two organisms. To our knowledge, this study is the first to indicate that Sidr honey is effective at inducing cell lysis and identify target genes at the genetic level that might be involved in this process.Export Options
About this article
Cite this article as:
Al-kafaween A. Mohammad*, Hilmi Mohd Abu Bakar , Al-Jamal A. Nagi Hamid*, Al-Groom M. Rania, Elsahoryi A. Nour and Al-Sayyed Hiba, Potential Antibacterial Activity of Yemeni Sidr Honey Against Pseudomonas aeruginosa and Streptococcus pyogenes, Anti-Infective Agents 2021; 19 (4) : e130621192336 . https://dx.doi.org/10.2174/2211352519666210319100204
DOI https://dx.doi.org/10.2174/2211352519666210319100204 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology Selected Abstracts from 2011 ISAPP Congress in Berlin Adolescence-A Second Chance?
Adolescent Psychiatry Recent Patents on Oral Insulin Delivery
Recent Patents on Drug Delivery & Formulation Effect on Morphology, Osmotic Fragility and Electro Kinetic Potential of Erythrocytes in Hypertension
Current Hypertension Reviews New Approaches to Providing Individualized Diabetes Care in the 21st Century
Current Diabetes Reviews CD31+ Circulating Angiogenic Cell Number and Subtypes are Reduced in Individuals with Chronic Stroke
Current Neurovascular Research Treating Diabetes Mellitus in Older and Oldest Old Patients
Current Pharmaceutical Design The Bid to Lose Weight: Impact of Social Media on Weight Perceptions, Weight Control and Diabetes
Current Diabetes Reviews Hypothyroidism and Cardiovascular Disease: Factors, Mechanism and Future Perspectives
Current Medicinal Chemistry Formulation and Characterization of Gliclazide Oral Dissolving Films
Drug Delivery Letters Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress
Current Topics in Medicinal Chemistry Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review
Current Drug Safety A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Mini-Reviews in Medicinal Chemistry Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
Current Vascular Pharmacology Is Erectile Dysfunction an Example of Abnormal Endothelial Function?
Current Vascular Pharmacology The Effects of Psychotropic Drugs on the Regulation of Glucose Metabolism
Current Diabetes Reviews Clinical Use of Intracoronary Gene Transfer of Fibroblast Growth Factor for Coronary Artery Disease
Current Gene Therapy Withdrawal Notice: Burden of Thyroid Dysfunction on Type 2 Diabetes Mellitus Patients with Emphasis on its Prevalence and Pattern of Presentation: A Case Controlled Study
Current Diabetes Reviews Mitochondria-Targeted Drugs
Current Molecular Pharmacology Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design